These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19154630)

  • 21. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
    Chausmer AL; Katz JL
    Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of early postnatal MK-801 treatment on behavioral properties in rats: Differences according to treatment schedule.
    Kawabe K; Miyamoto E
    Behav Brain Res; 2019 Sep; 370():111926. PubMed ID: 31029708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats.
    Wedzony K; Gołembiowska K; Zazula M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):555-62. PubMed ID: 7870195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.
    Gresack JE; Seymour PA; Schmidt CJ; Risbrough VB
    Psychopharmacology (Berl); 2014 May; 231(10):2189-97. PubMed ID: 24363077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of neonatal MK-801 treatment on prepulse inhibition in young adult rats.
    Uehara T; Sumiyoshi T; Seo T; Itoh H; Matsuoka T; Suzuki M; Kurachi M
    Psychopharmacology (Berl); 2009 Nov; 206(4):623-30. PubMed ID: 19370341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apomorphine-induced behavioural sensitization in rats: individual differences, role of dopamine and NMDA receptors.
    Võikar V; Soosaar A; Volke V; Kõks S; Bourin M; Männistö PT; Vasar E
    Eur Neuropsychopharmacol; 1999 Dec; 9(6):507-14. PubMed ID: 10625119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.
    De Bundel D; Femenía T; DuPont CM; Konradsson-Geuken Å; Feltmann K; Schilström B; Lindskog M
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2041-51. PubMed ID: 23672849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats.
    de Jong IE; van den Buuse M
    Neuropharmacology; 2006 Sep; 51(3):438-46. PubMed ID: 16740279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
    Depoortère R; Auclair AL; Bardin L; Bruins Slot L; Kleven MS; Colpaert F; Vacher B; Newman-Tancredi A
    Br J Pharmacol; 2007 May; 151(2):266-77. PubMed ID: 17375085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats.
    Carr KD; Kim GY; Cabeza de Vaca S
    Psychopharmacology (Berl); 2001 Apr; 154(4):420-8. PubMed ID: 11349397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.
    Wakabayashi C; Numakawa T; Ooshima Y; Hattori K; Kunugi H
    Psychopharmacology (Berl); 2015 Dec; 232(24):4393-400. PubMed ID: 26359228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live rats.
    Daya RP; Bhandari JK; Hui PA; Tian Y; Farncombe T; Mishra RK
    Neuropharmacology; 2014 Feb; 77():325-33. PubMed ID: 24140927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
    Goktalay T; Buyukuysal S; Uslu G; Coskun AS; Yorgancioglu A; Kayir H; Uzbay T; Goktalay G
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():54-60. PubMed ID: 24632394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
    Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation.
    Kreipke CW; Walker PD
    Synapse; 2004 Jul; 53(1):28-35. PubMed ID: 15150738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic prenatal MK-801 treatment on object recognition, cognitive flexibility, and drug-induced locomotor activity in juvenile and adult rat offspring.
    Gallant S; Welch L; Martone P; Shalev U
    Behav Brain Res; 2017 Jun; 328():62-69. PubMed ID: 28390877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition.
    Schlumberger C; Schäfer D; Barberi C; Morè L; Nagel J; Pietraszek M; Schmidt WJ; Danysz W
    Behav Pharmacol; 2009 Feb; 20(1):56-66. PubMed ID: 19179851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.
    Uehara T; Sumiyoshi T; Seo T; Matsuoka T; Itoh H; Suzuki M; Kurachi M
    Brain Res; 2010 Sep; 1352():223-30. PubMed ID: 20633540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensorimotor gating in neurotensin-1 receptor null mice.
    Feifel D; Pang Z; Shilling PD; Melendez G; Schreiber R; Button D
    Neuropharmacology; 2010 Jan; 58(1):173-8. PubMed ID: 19596359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.